Irvine-Based Botox Company Transcends Plastics, Sells Shares After FDA Approves Face-Plumper For Use On Chronic Migraines
Stock-market hawks saw this one from a mile away. Allergan shares jumped over 5 percent last week, after the U.S. Food and Drug Administration approved its anti-wrinkle housewife staple Botox for use on chronic migraine headaches. Ironic, seeing as the Irvine drug company just lost $600 million in an October......
